These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25202944)

  • 21. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide.
    Zhao L; Liang L; Guo M; Li M; Yu X; Wang Y; Wang Y
    Curr Top Med Chem; 2021 Oct; 21(14):1268-1284. PubMed ID: 34620053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, characterization, and evaluation of a novel amphiphilic polymer RGD-PEG-Chol for target drug delivery system.
    Zeng S; Wu F; Li B; Song X; Zheng Y; He G; Peng C; Huang W
    ScientificWorldJournal; 2014; 2014():546176. PubMed ID: 24578646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycyrrhetinic Acid and TAT Peptide Modified Dual-functional Liposomes for Treatment of Hepatocellular Cancer.
    Huang S; Ren D; Wu X; Li M; Yu X; Nie X; Wang Y; Wang Y
    Curr Top Med Chem; 2020; 20(27):2493-2505. PubMed ID: 32703132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
    Yuan M; Qiu Y; Zhang L; Gao H; He Q
    Drug Deliv; 2016 May; 23(4):1171-83. PubMed ID: 26036724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual Receptor Targeting Cell Penetrating Peptide Modified Liposome for Glioma and Breast Cancer Postoperative Recurrence Therapy.
    Qiu Y; Yu Q; Liu Y; Tang J; Wang X; Lu Z; Xu Z; He Q
    Pharm Res; 2018 Apr; 35(7):130. PubMed ID: 29700620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer.
    Yang Y; Zhao Z; Xie C; Zhao Y
    Chem Phys Lipids; 2020 May; 228():104882. PubMed ID: 32017901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined integrin α
    Qi N; Zhang S; Zhou X; Duan W; Gao D; Feng J; Li A
    J Nanobiotechnology; 2021 Dec; 19(1):446. PubMed ID: 34949198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposomes actively recognizing the glucose transporter GLUT
    Fu Q; Zhao Y; Yang Z; Yue Q; Xiao W; Chen Y; Yang Y; Guo L; Wu Y
    Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800219. PubMed ID: 30609116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.
    Chen X; Plasencia C; Hou Y; Neamati N
    J Med Chem; 2005 Feb; 48(4):1098-106. PubMed ID: 15715477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells.
    Zhu Y; Wang A; Zhang S; Kim J; Xia J; Zhang F; Wang D; Wang Q; Wang J
    J Adv Res; 2023 Jul; 49():159-173. PubMed ID: 36167294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
    Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
    Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cytological Study in vitro on Co-delivery of siRNA and Paclitaxel within Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Tumors].
    Huang R; Yao X; Chen Y; Sun X; Lin Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Feb; 33(1):108-14. PubMed ID: 27382749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
    Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
    J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy.
    Wu H; Yao L; Mei J; Li F
    Int J Clin Exp Pathol; 2015; 8(1):207-16. PubMed ID: 25755707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-targeting liposomes with active recognition of GLUT
    Pu Y; Zhang H; Peng Y; Fu Q; Yue Q; Zhao Y; Guo L; Wu Y
    Eur J Med Chem; 2019 Dec; 183():111720. PubMed ID: 31553933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimeric System of RGD-Grafted PMMA-Nanoparticles as a Targeted Drug- Delivery System for Paclitaxel.
    Gibbens-Bandala BV; Ocampo-García BE; Ferro-Flores G; Morales-Avila E; Ancira-Cortez A; Jaimes-Aguirre L
    Curr Pharm Des; 2017; 23(23):3415-3422. PubMed ID: 28403791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. K237-modified thermosensitive liposome enhanced the delivery efficiency and cytotoxicity of paclitaxel in vitro.
    Fu X; Lu Y; Guo J; Liu H; Deng A; Kuang C; Xie X
    J Liposome Res; 2019 Mar; 29(1):86-93. PubMed ID: 29671386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
    Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
    J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes.
    Niu R; Zhao P; Wang H; Yu M; Cao S; Zhang F; Chang J
    J Drug Target; 2011 Jun; 19(5):373-81. PubMed ID: 20677917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.